These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2230260)

  • 81. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.
    Suchland RJ; Geisler WM; Stamm WE
    Antimicrob Agents Chemother; 2003 Feb; 47(2):636-42. PubMed ID: 12543671
    [TBL] [Abstract][Full Text] [Related]  

  • 82. In-vitro activity of 3-azinomethyl-rifamycin (SPA-S-565) against Chlamydia trachomatis.
    Zanetti S; Usai D; Nonis A; Fadda G
    J Antimicrob Chemother; 1996 Feb; 37(2):357-9. PubMed ID: 8707747
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.
    Hammerschlag MR; Gleyzer A
    Antimicrob Agents Chemother; 1983 Mar; 23(3):493-4. PubMed ID: 6847175
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.
    Kuo CC; Wang SP; Grayston JT
    Antimicrob Agents Chemother; 1977 Jul; 12(1):80-3. PubMed ID: 883821
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin.
    Treharne JD; Yearsley PJ; Ballard RC
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1393-4. PubMed ID: 2552911
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.
    How SJ; Hobson D; Hart CA; Quayle E
    J Antimicrob Chemother; 1985 Apr; 15(4):399-404. PubMed ID: 3891709
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of mercury (Hg) in resistant infections & effective treatment of Chlamydia trachomatis and Herpes family viral infections (and potential treatment for cancer) by removing localized Hg deposits with Chinese parsley and delivering effective antibiotics using various drug uptake enhancement methods.
    Omura Y; Beckman SL
    Acupunct Electrother Res; 1995; 20(3-4):195-229. PubMed ID: 8686573
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Rifampin in chlamydial infections.
    Schachter J
    Rev Infect Dis; 1983; 5 Suppl 3():S562-4. PubMed ID: 6635446
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Antibiotic susceptibility of Chlamydia trachomatis.
    Blackman HJ; Yoneda C; Dawson CR; Schachter J
    Antimicrob Agents Chemother; 1977 Dec; 12(6):673-7. PubMed ID: 931365
    [TBL] [Abstract][Full Text] [Related]  

  • 90. An in-vitro investigation of synergy and antagonism between antimicrobials against Chlamydia trachomatis.
    How SJ; Hobson D; Hart CA; Webster RE
    J Antimicrob Chemother; 1985 May; 15(5):533-8. PubMed ID: 4008386
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Techniques for culturing and determining antimicrobial susceptibility of Chlamydia trachomatis.
    Rota TR
    Arch Androl; 1980 Feb; 4(1):63-9. PubMed ID: 7356376
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
    Chirgwin K; Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1634-5. PubMed ID: 2817862
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection.
    Oriel JD; Reeve P; Powis P; Miller A; Nicol CS
    Br J Vener Dis; 1972 Dec; 48(6):429-36. PubMed ID: 4568463
    [No Abstract]   [Full Text] [Related]  

  • 94. Evaluation of antibiotic sensitivity of Chlamydia trachomatis using RT-PCR.
    Misyurina OY; Shipitsina EV; Parfenova TM; Lazarev VN; Savicheva AM; Govorun VM
    Bull Exp Biol Med; 2002 Mar; 133(3):308-10. PubMed ID: 12360359
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The 7.5-kb common plasmid is unrelated to the drug susceptibility of Chlamydia trachomatis.
    Miyashita N; Matsumoto A; Fukano H; Niki Y; Matsushima T
    J Infect Chemother; 2001 Jun; 7(2):113-6. PubMed ID: 11455502
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Antibiotic resistance in Chlamydiae.
    Sandoz KM; Rockey DD
    Future Microbiol; 2010 Sep; 5(9):1427-42. PubMed ID: 20860486
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Antimicrobial susceptibility and serotyping of Chlamydia trachomatis strains isolated before and after treatment with ciprofloxacin and doxycycline.
    van der Willigen AH; van Rijsoord-Vos T; Wagenvoort JH; Stamm WE; Suchland RJ; Stolz E
    Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):561-3. PubMed ID: 1526246
    [No Abstract]   [Full Text] [Related]  

  • 98. [Evaluation of in vivo activity of antibiotics against Chlamydia trachomatis in mice].
    Bannai H; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1988 Mar; 62(3):246-52. PubMed ID: 3147305
    [No Abstract]   [Full Text] [Related]  

  • 99. In vitro activity of clindamycin against Chlamydia trachomatis.
    Bowie WR
    Sex Transm Dis; 1981; 8(3):220-1. PubMed ID: 7292214
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Simple resazurin-based microplate assay for measuring Chlamydia infections.
    Osaka I; Hefty PS
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2838-40. PubMed ID: 23507273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.